| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.
|
Hum Reprod
|
2011
|
5.49
|
|
2
|
A systematic review of tests predicting ovarian reserve and IVF outcome.
|
Hum Reprod Update
|
2006
|
4.24
|
|
3
|
The lutropin/choriogonadotropin receptor, a 2002 perspective.
|
Endocr Rev
|
2002
|
2.89
|
|
4
|
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.
|
Cell
|
1995
|
2.89
|
|
5
|
The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology.
|
Endocr Rev
|
1997
|
2.44
|
|
6
|
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
|
Hum Reprod
|
2011
|
2.10
|
|
7
|
Sub-optimal responders following controlled ovarian stimulation: an overlooked group?
|
Hum Reprod
|
2015
|
2.09
|
|
8
|
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles.
|
Cochrane Database Syst Rev
|
2011
|
1.83
|
|
9
|
Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis.
|
Hum Reprod Update
|
2010
|
1.72
|
|
10
|
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.
|
J Clin Endocrinol Metab
|
2000
|
1.60
|
|
11
|
Optimum number of oocytes for a successful first IVF treatment cycle.
|
Reprod Biomed Online
|
2006
|
1.53
|
|
12
|
Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle.
|
Science
|
1981
|
1.37
|
|
13
|
Ovarian reserve.
|
Ann N Y Acad Sci
|
2008
|
1.35
|
|
14
|
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
|
Hum Reprod Update
|
2014
|
1.35
|
|
15
|
The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
|
Hum Reprod Update
|
2008
|
1.26
|
|
16
|
Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders.
|
Fertil Steril
|
2001
|
1.18
|
|
17
|
Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
|
Hum Reprod
|
2009
|
1.15
|
|
18
|
Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?
|
Hum Reprod Update
|
2011
|
1.09
|
|
19
|
Active smoking compromises IVF outcome and affects ovarian reserve.
|
Reprod Biomed Online
|
2008
|
1.04
|
|
20
|
Polymorphisms of the luteinizing hormone/chorionic gonadotropin receptor gene: association with maldescended testes and male infertility.
|
Pharmacogenet Genomics
|
2008
|
0.94
|
|
21
|
The chromosomal localization of the human follicle-stimulating hormone receptor gene (FSHR) on 2p21-p16 is similar to that of the luteinizing hormone receptor gene.
|
Genomics
|
1993
|
0.94
|
|
22
|
Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.
|
Fertil Steril
|
2013
|
0.93
|
|
23
|
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.
|
Fertil Steril
|
2014
|
0.92
|
|
24
|
Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
|
Reprod Biomed Online
|
2013
|
0.92
|
|
25
|
Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.
|
Mol Cell Endocrinol
|
2007
|
0.88
|
|
26
|
Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21.
|
Cytogenet Cell Genet
|
1990
|
0.87
|
|
27
|
Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis.
|
Mol Genet Metab
|
2011
|
0.87
|
|
28
|
Genetic profile of SNP(s) and ovulation induction.
|
Curr Pharm Biotechnol
|
2012
|
0.86
|
|
29
|
Lutropin receptor function: insights from natural, engineered, and computer-simulated mutations.
|
IUBMB Life
|
2001
|
0.85
|
|
30
|
Pharmacogenetics of follicle-stimulating hormone action.
|
Curr Opin Endocrinol Diabetes Obes
|
2012
|
0.85
|
|
31
|
A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein.
|
Mol Cell Endocrinol
|
2006
|
0.84
|
|
32
|
The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
|
Clin Endocrinol (Oxf)
|
2014
|
0.83
|
|
33
|
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population.
|
Clin Endocrinol (Oxf)
|
2012
|
0.81
|
|
34
|
Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.
|
Hum Reprod
|
2016
|
0.81
|
|
35
|
Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response.
|
Pharmacogenet Genomics
|
2013
|
0.80
|
|
36
|
Localization of the human FSH receptor to chromosome 2 p21 using a genomic probe comprising exon 10.
|
J Mol Endocrinol
|
1994
|
0.80
|
|
37
|
Structural aspects of luteinizing hormone receptor: information from molecular modeling and mutagenesis.
|
Endocrine
|
2002
|
0.78
|
|
38
|
Challenges in pharmacogenetics.
|
Eur J Clin Pharmacol
|
2013
|
0.76
|
|
39
|
Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
|
Pharmacogenet Genomics
|
2016
|
0.75
|
|
40
|
Pharmacogenomics of ovulation induction: facilitating decisions on who, when and how to treat.
|
Pharmacogenomics
|
2009
|
0.75
|